Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function

Pescovitz, Mark D., Greenbaum, Carla J., Krause-Steinrauf, Heidi, Becker, Dorothy J., Gitelman, Stephen E., Goland, Robin, Gottlieb, Peter A., Marks, Jennifer B., McGee, Paula F., Moran, Antoinette M., Raskin, Philip, Rodriguez, Henry, Schatz, Desmond A., Wherrett, Diane, Wilson, Darrell M., Lachin, John M., Skyler, Jay S.·2009·New England Journal of Medicine

DOI 10.1056/nejmoa0904452

Cited by (1,000)

Items 101–200 of 1,000

Effect of rituximab on human in vivo antibody immune responses
Mark D. Pescovitz, Troy R. Torgerson, Hans D. Ochs, Elizabeth Ocheltree, Paula McGee, Heidi J Krause-Steinrauf, John M. Lachin, Jennifer D. Canniff, Carla J. Greenbaum, Kevan C. Herold et al. · 2011 · Journal of Allergy and Clinical Immunology
Identification of tetraspanin-7 as a target of autoantibodies in type 1 diabetes
McLaughlin, Kerry A., Richardson, Carolyn C., Ravishankar, Aarthi, Brigatti, Cristina, Liberati, Daniela, Lampasona, Vito, Piemonti, Lorenzo, Morgan, Diana, Feltbower, Richard G., Christie, Michael R. · 2016 · Diabetes
PhIP-Seq characterization of autoantibodies from patients with multiple sclerosis, type 1 diabetes and rheumatoid arthritis
H. Benjamin Larman, Uri Laserson, Luís Querol, Katrijn Verhaeghen, Nicole L. Solimini, George Jing Xu, Paul L. Klarenbeek, George McDonald Church, David A. Hafler, Robert M. Plenge et al. · 2013 · Journal of Autoimmunity
Circulating CXCR5+PD-1+ICOS+ Follicular T Helper Cells Are Increased Close to the Diagnosis of Type 1 Diabetes in Children With Multiple Autoantibodies
Tyyne Viisanen, Emmi‐Leena Ihantola, Kirsti Näntö‐Salonen, Heikki Hyöty, Noora Nurminen, Jenni Selvenius, Auni Juutilainen, Leena Moilanen, Jussi Pihlajamäki, Riitta Veijola et al. · 2016 · Diabetes
Mitochondrial DNA Activates the NLRP3 Inflammasome and Predisposes to Type 1 Diabetes in Murine Model
Daniela Carlos, Frederico R. C. Costa, Camila A. Pereira, Fernanda A. Rocha, Juliana Navarro Ueda Yaochite, Gabriela Gonçalves de Oliveira, Fernando Silva Carneiro, Rita C. Tostes, Simone Gusmão Ramos, Dario S. Zamboni et al. · 2017 · Frontiers in Immunology
Prediction and Prevention of Type 1 Diabetes
Marina Primavera, Cosimo Giannini, Francesco Chiarelli · 2020 · Frontiers in Endocrinology
Continuous inhibitory signaling by both SHP-1 and SHIP-1 pathways is required to maintain unresponsiveness of anergic B cells
Andrew Getahun, Nicole A. Beavers, Sandy R. Larson, Mark Jay Shlomchik, John C. Cambier · 2016 · The Journal of Experimental Medicine
Immune therapy in type 1 diabetes mellitus
Åke Lernmark, Helena Elding Larsson · 2013 · Nature Reviews Endocrinology
Stopping Type 1 Diabetes: Attempts to Prevent or Cure Type 1 Diabetes in Man
Jay S. Skyler, Camillo Ricordi · 2010 · Diabetes
Interleukin-10+ Regulatory B Cells Arise Within Antigen-Experienced CD40+ B Cells to Maintain Tolerance to Islet Autoantigens
Sonja Kleffel, Andrea Vergani, Sara Tezza, Moufida Ben Nasr, Monika A. Niewczas, Florence Susan Wong, Roberto Bassi, Francesca D’Addio, Tobias Schatton, Reza Abdi et al. · 2014 · Diabetes
Banting Lecture 2009: An Unfinished Journey: Molecular Pathogenesis to Prevention of Type 1A Diabetes
George S. Eisenbarth · 2010 · Diabetes
Synergistic Reversal of Type 1 Diabetes in NOD Mice With Anti-CD3 and Interleukin-1 Blockade
Vitaly G. Ablamunits, Octavian Henegariu, Jakob Bondo Hansen, Lynn Opare-Addo, Paula Preston‐Hurlburt, Pere Santamaría, Thomas R Mandrup-Poulsen, Kevan C. Herold · 2011 · Diabetes
Restoring the balance: immunotherapeutic combinations for autoimmune disease
Dawn Elaine Smilek, Mario R. Ehlers, Gerald T. Nepom · 2014 · Disease Models & Mechanisms
Loss of Anergic B Cells in Prediabetic and New-Onset Type 1 Diabetic Patients
Mia J. Smith, Thomas Alexander Packard, Shannon K. O’Neill, Carole Henry, Min Huang, Lisa Fitzgerald-Miller, Daniel F. Stowell, Rochelle M. Hinman, Patrick C. Wilson, Peter A. Gottlieb et al. · 2014 · Diabetes
Immune therapy for type 1 diabetes mellitus—what is unique about anti-CD3 antibodies?
Lucienne Chatenoud · 2010 · Nature Reviews Endocrinology
Selective inhibitors of phosphoinositide 3-kinase delta: modulators of B-cell function with potential for treating autoimmune inflammatory diseases and B-cell malignancies
Kamal D. Puri, Michael R. Gold · 2012 · Frontiers in Immunology
Circulating CXCR5−PD-1hi peripheral T helper cells are associated with progression to type 1 diabetes
Ilse Ekman, Emmi‐Leena Ihantola, Tyyne Viisanen, Deepak A. Rao, Kirsti Näntö‐Salonen, Mikael Knip, Riitta Veijola, Jorma Toppari, Jorma Ilonen, Tuure T. Kinnunen · 2019 · Diabetologia
Life and death of β cells in Type 1 diabetes: A comprehensive review
Nicholas S. Wilcox, Jinxiu Rui, Matthias Hebrok, Kevan C. Herold · 2016 · Journal of Autoimmunity
Diabetogenic T lymphocytes in human Type 1 diabetes
Roep, Bart O, Peakman, Mark · 2011 · Current Opinion in Immunology
TGF-β–Induced Regulatory T Cells Directly Suppress B Cell Responses through a Noncytotoxic Mechanism
Anping Xu, Ya Liu, Weiqian Chen, Julie Wang, Youqiu Xue, Feng Huang, Liming Rong, Jin Lin, Dahai Liu, Mei Yan et al. · 2016 · The Journal of Immunology
Insulitis and characterisation of infiltrating T cells in surgical pancreatic tail resections from patients at onset of type 1 diabetes
Lars Krogvold, Anna Wiberg, Bjørn Edwin, Trond A Buanes, Frode Lars Jahnsen, Kristian Folkvord Hanssen, Erik N. V. Larsson, Olle Korsgren, Oskar Skog, Knut Dahl‐Jørgensen · 2015 · Diabetologia
Humoral Autoimmunity in Type 1 Diabetes: Prediction, Significance, and Detection of Distinct Disease Subtypes
M. Pietropaolo, Roberto Towns, George S. Eisenbarth · 2012 · Cold Spring Harbor Perspectives in Medicine
Defining Pathways for Development of Disease-Modifying Therapies in Children With Type 1 Diabetes: A Consensus Report
Diane K. Wherrett, Jane L. Chiang, Alan M. Delamater, Linda Anne DiMeglio, Stephen Eric Gitelman, Peter A. Gottlieb, Kevan C. Herold, Daniel J. Lovell, Trevor John Orchard, Christopher M. Ryan et al. · 2015 · Diabetes Care
Combination therapy with sitagliptin and lansoprazole in patients with recent-onset type 1 diabetes (REPAIR-T1D): 12-month results of a multicentre, randomised, placebo-controlled, phase 2 trial
Kurt Griffin, Paul A. Thompson, Michael Everett Gottschalk, Jennifer H. Kyllo, Alex Rabinovitch · 2014 · The Lancet Diabetes & Endocrinology
Rituximab does not reset defective early B cell tolerance checkpoints
Nicolas Chamberlain, Christopher Massad, Tyler Oe, Tineke Cantaert, Kevan C. Herold, Eric Meffre, the Type 1 Diabetes TrialNet Pathway to Prevention Study Group · 2015 · Journal of Clinical Investigation
Reduction in CD4 Central Memory T-Cell Subset in Costimulation Modulator Abatacept-Treated Patients With Recent-Onset Type 1 Diabetes Is Associated With Slower C-Peptide Decline
Tihamer Orban, Craig A. Beam, Ping Xu, Keith Moore, Qi Jiang, Jun Deng, Sarah Müller, Peter A. Gottlieb, Lisa M. Spain, Mark Peakman et al. · 2014 · Diabetes
Immunomodulatory therapy to preserve pancreatic β-cell function in type 1 diabetes
Frank Waldron-Lynch, Kevan C. Herold · 2011 · Nature Reviews Drug Discovery
Antithymocyte globulin therapy for patients with recent-onset type 1 diabetes: 2 year results of a randomised trial
Stephen Eric Gitelman, Peter A. Gottlieb, Eric I. Felner, Steven Matthew Willi, Lynda K. Fisher, Antoinette Moran, Michael Everett Gottschalk, Wayne V. Moore, Ashley Pinckney, Lynette Keyes-Elstein et al. · 2016 · Diabetologia
Histone deacetylases 1 and 3 but not 2 mediate cytokine-induced beta cell apoptosis in INS-1 cells and dispersed primary islets from rats and are differentially regulated in the islets of type 1 diabetic children
Morten Lundh, Dan Ploug Christensen, Mette Damgaard Nielsen, Sarah J. Richardson, Mattias Salling Dahllöf, Tine Skovgaard, Jens Berthelsen, Charles Anthony Dinarello, Andrea Stevenazzi, Paolo Mascagni et al. · 2012 · Diabetologia
CXCR1/2 Inhibition Blocks and Reverses Type 1 Diabetes in Mice
Antonio Citro, Andrea Valle, Elisa Cantarelli, Alessia Mercalli, Silvia Pellegrini, Daniela Liberati, Luisa Daffonchio, Olga Kastsiuchenka, Pier Adelchi Ruffini, Manuela Battaglia et al. · 2014 · Diabetes
Evolution of Ectopic Lymphoid Neogenesis and In Situ Autoantibody Production in Autoimmune Nonobese Diabetic Mice: Cellular and Molecular Characterization of Tertiary Lymphoid Structures in Pancreatic Islets
Elisa Astorri, Michele Bombardieri, Silvia Gabba, Mark Peakman, Paolo Pozzilli, Costantino Pitzalis · 2010 · The Journal of Immunology
The IL-2/IL-2R system: from basic science to therapeutic applications to enhance immune regulation
Allison L. Bayer, Alberto Pugliese, Thomas R. Malek · 2013 · Immunologic Research
Thinking bedside at the bench: the NOD mouse model of T1DM
James Christopher Reed, Kevan C. Herold · 2015 · Nature Reviews Endocrinology
Rituximab Selectively Suppresses Specific Islet Antibodies
Liping Yu, Kevan C. Herold, Heidi J Krause-Steinrauf, Paula L. McGee, Brian N. Bundy, Alberto Pugliese, Jeff Krischer, George S. Eisenbarth, for the Type 1 Diabetes TrialNet Anti-CD20 Study Group · 2011 · Diabetes
Changing the landscape for type 1 diabetes: the first step to prevention
Dayan, Colin M, Korah, Maria, Tatovic, Danijela, Bundy, Brian N, Herold, Kevan C · 2019 · The Lancet
Prevention and Reversal of Type 1 Diabetes—Past Challenges and Future Opportunities
Jay S. Skyler · 2015 · Diabetes Care
Galectin-9 and T Cell Immunoglobulin Mucin-3 Pathway Is a Therapeutic Target for Type 1 Diabetes
Motoko Kanzaki, Jun Wada, Koichi Sugiyama, Atsuko Nakatsuka, Sanae Teshigawara, Kazutoshi Murakami, Kentaro Inoue, Takahiro Terami, Akihiro Katayama, Jun Eguchi et al. · 2011 · Endocrinology
Dual-Sized Microparticle System for Generating Suppressive Dendritic Cells Prevents and Reverses Type 1 Diabetes in the Nonobese Diabetic Mouse Model
Jamal S. Lewis, Joshua Michael Stewart, Gregory P. Marshall, Matthew R. Carstens, Ying Zhang, Natalia V. Dolgova, Chang‐Qing Xia, Todd M. Brusko, Clive Henry Wasserfall, Michael J Clare-Salzler et al. · 2019 · ACS Biomaterials Science & Engineering
Innate inflammation in type 1 diabetes
Susanne M. Cabrera, Angela M. Henschel, Martin J. Hessner · 2015 · Translational research
Understanding and preventing type 1 diabetes through the unique working model of TrialNet
Manuela Battaglia, Mark Stuart Anderson, Jane Hoyt Buckner, Susan Michelle Geyer, Peter A. Gottlieb, Thomas W. H. Kay, Åke Lernmark, Sarah Müller, Alberto Pugliese, Bart O. Roep et al. · 2017 · Diabetologia
The Long and Winding Road to Understanding and Conquering Type 1 Diabetes
Pere Santamaría · 2010 · Immunity
Increased T Cell Proliferative Responses to Islet Antigens Identify Clinical Responders to Anti-CD20 Monoclonal Antibody (Rituximab) Therapy in Type 1 Diabetes
Kevan C. Herold, Mark D. Pescovitz, Paula McGee, Heidi J Krause-Steinrauf, Lisa M. Spain, Kasia Bourcier, Adam L. Asare, Zhugong Liu, John M. Lachin, H. M. Dosch et al. · 2011 · The Journal of Immunology
Type 1 Diabetes TrialNet: A Multifaceted Approach to Bringing Disease-Modifying Therapy to Clinical Use in Type 1 Diabetes
Polly J. Bingley, Diane K. Wherrett, Ann Shultz, Lisa E. Rafkin, Mark A. Atkinson, Carla J. Greenbaum · 2018 · Diabetes Care
The Effect of Age on the Progression and Severity of Type 1 Diabetes: Potential Effects on Disease Mechanisms
Pia Leete, Roberto Mallone, Sarah J. Richardson, Jay M. Sosenko, MARIA JOSE REDONDO, Carmella Evans‐Molina · 2018 · Current Diabetes Reports
Immune Therapy and β-Cell Death in Type 1 Diabetes
Jasmin Lebastchi, Songyan Deng, Amir H. Lebastchi, Isabel Beshar, Stephen Eric Gitelman, Steven Matthew Willi, Peter A. Gottlieb, Eitan M. Akirav, Jeffrey A. Bluestone, Kevan C. Herold · 2013 · Diabetes
Memory of tolerance and induction of regulatory T cells by erythrocyte-targeted antigens
Alizée J Grimm, Stephan Kontos, Giacomo Diaceri, Xavier Quaglia-Thermes, Jeffrey A. Hubbell · 2015 · Scientific Reports
Combination immunotherapies for type 1 diabetes mellitus
Paolo Pozzilli, Ernesto Maddaloni, Raffaella Buzzetti · 2015 · Nature Reviews Endocrinology
Extended evaluation of the safety and efficacy of GAD treatment of children and adolescents with recent-onset type 1 diabetes: a randomised controlled trial
Johnny Ludvigsson, M. Hjorth, Mikael Chéramy, Stina Axelsson, M. Pihl, Gun Forsander, Nils-Osten Nilsson, B.-O. Samuelsson, T. Wood, Jan Åman et al. · 2010 · Diabetologia
Proinsulin/Insulin Autoantibodies Measured With Electrochemiluminescent Assay Are the Earliest Indicator of Prediabetic Islet Autoimmunity
Liping Yu, Fran Dong, Dongmei Miao, Alexandra Fouts, Janet M. Wenzlau, Andrea K. Steck · 2013 · Diabetes Care
Type 1 Diabetes
Åke Lernmark, Shehab Alshiekh · 2016 · Elsevier eBooks
Development of the Nonobese Diabetic Mouse and Contribution of Animal Models for Understanding Type 1 Diabetes
Yoko Mullen · 2017 · Pancreas
The role of the innate immune system in destruction of pancreatic beta cells in NOD mice and humans with type I diabetes
Ningwen Tai, Florence Susan Wong, Wen Li · 2016 · Journal of Autoimmunity
Preliminary studies related to anti-interleukin-1β therapy in children with newly diagnosed type 1 diabetes
Kathryn Sumpter, Soumya Adhikari, Ellen K. Grishman, Perrin C. White · 2011 · Pediatric Diabetes
Mechanisms of Regulatory B cell Function in Autoimmune and Inflammatory Diseases beyond IL-10
Avijit Ray, Bonnie N. Dittel · 2017 · Journal of Clinical Medicine
Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1 in juvenile diabetes
Ciriana Orabona, Giada Mondanelli, Maria Teresa Pallotta, Agostinho Carvalho, Elisa Albini, Francesca Fallarino, Carmine Vacca, Claudia Volpi, Maria Laura Belladonna, Maria Giulia Berioli et al. · 2018 · JCI Insight
Islet inflammation in human type 1 diabetes mellitus
Noel G. Morgan, Pia Leete, Alan K. Foulis, Sarah J. Richardson · 2014 · IUBMB Life
Decline of C-peptide during the first year after diagnosis of Type 1 diabetes in children and adolescents
Johnny Ludvigsson, Annelie Carlsson, A. Deli, Gun Forsander, Sten Anders Ivarsson, Ingrid Skelton Kockum, Bengt Lindblad, Claude Marcus, Åke Lernmark, Ulf Samuelsson · 2013 · Diabetes Research and Clinical Practice
Prediction and prevention of Type 1 diabetes mellitus
Li Zhang, George S. Eisenbarth · 2010 · Journal of Diabetes
Progress in immune-based therapies for type 1 diabetes
Matthias von Herrath, Mark Peakman, Bart O. Roep · 2013 · Clinical & Experimental Immunology
Kinetics of the Post-Onset Decline in Zinc Transporter 8 Autoantibodies in Type 1 Diabetic Human Subjects
Janet M. Wenzlau, Melanie Walter, Thomas J. Gardner, Lisa M. Frisch, Liping Yu, George S. Eisenbarth, Anette‐Gabriele Ziegler, Howard W. Davidson, John C. Hutton · 2010 · The Journal of Clinical Endocrinology & Metabolism
Durable preservation of antiviral antibodies after CD19-directed chimeric antigen receptor T-cell immunotherapy
Joshua Aiden Hill, Elizabeth M. Krantz, Kevin Anthony Hay, Sayan Dasgupta, Terry Stevens‐Ayers, Rachel Bender Ignacio, Merav Bar, Joyce Maalouf, Sindhu Cherian, Xueyan Chen et al. · 2019 · Blood Advances
GAD-alum treatment induces GAD65-specific CD4+CD25highFOXP3+ cells in type 1 diabetic patients
Maria Hjorth, Stina Axelsson, Anna Rydén, Maria Faresjö, Johnny Ludvigsson, Rosaura Casas · 2010 · Clinical Immunology
Therapeutic Antibodies in Medicine
Prerna Sharma, Rahul V. Joshi, Robert Pritchard, Kevin Xu, Maya A. Eicher · 2023 · Molecules
Insulin-dependent diabetes induced by pancreatic beta cell expression of IL-15 and IL-15Rα
Jing Chen, Lionel Feigenbaum, Parirokh Awasthi, Donna O. Butcher, Miriam R. Anver, Yelena G. Golubeva, Richard N. Bamford, Xiaojie Zhang, Mark B. St. Claire, Craig J. Thomas et al. · 2013 · Proceedings of the National Academy of Sciences
Anti-Islet Autoantibodies Trigger Autoimmune Diabetes in the Presence of an Increased Frequency of Islet-Reactive CD4 T Cells
Diego G. Silva, Stephen R. Daley, Jennifer J. Hogan, Sau K. Lee, Charis E. Teh, Daniel Y. Hu, Kong‐Peng Lam, Christopher Carl Goodnow, Carola G. Vinuesa · 2011 · Diabetes
Loss of Intra-Islet CD20 Expression May Complicate Efficacy of B-Cell–Directed Type 1 Diabetes Therapies
DAVID V. SERREZE, Harold D. Chapman, Marijke Niens, Robert Dunn, Marilyn R. Kehry, John P. Driver, Michael J. Haller, Clive Henry Wasserfall, Mark A. Atkinson · 2011 · Diabetes
C-peptide levels in subjects followed longitudinally before and after type 1 diabetes diagnosis in TrialNet
Bogun, Magdalena M., Bundy, Brian N., Goland, Robin S., Greenbaum, Carla J. · 2020 · Diabetes Care
B cells as effectors and regulators of autoimmunity
Eliana Mariño, Shane T. Grey · 2012 · Autoimmunity
Exhausted-like CD8+ T cell phenotypes linked to C-peptide preservation in alefacept-treated T1D subjects
Kirsten E. Diggins, Elisavet Serti, VIRGINIA S. MUIR, Mario G. Rosasco, Tingting Lü, Elisa Balmas, Gerald T. Nepom, Sarah Alice Long, Peter S. Linsley · 2020 · JCI Insight
Anti-cytokine therapies in T1D: Concepts and strategies
Gerald T. Nepom, Mario R. Ehlers, Thomas R Mandrup-Poulsen · 2013 · Clinical Immunology
Progressive Erosion of β-Cell Function Precedes the Onset of Hyperglycemia in the NOD Mouse Model of Type 1 Diabetes
Diego Ize-Ludlow, Yaima Luzardo Lightfoot, Matthew Parker, Song Xue, Clive Henry Wasserfall, Michael J. Haller, Desmond Schatz, Dorothy J. Becker, Mark A. Atkinson, Clayton E. Mathews · 2011 · Diabetes
B cells and atherosclerosis
Prasad Srikakulapu, Coleen A. McNamara · 2017 · American Journal of Physiology-Heart and Circulatory Physiology
Comparing Beta Cell Preservation Across Clinical Trials in Recent-Onset Type 1 Diabetes
Laura M. Jacobsen, Brian N. Bundy, Madison N. Greco, Desmond Schatz, Mark A. Atkinson, Todd M. Brusko, Clayton E. Mathews, Kevan C. Herold, Stephen Eric Gitelman, Jeffrey P. Krischer et al. · 2020 · Diabetes Technology & Therapeutics
On the Etiology of Type 1 Diabetes
Stella Korsgren, Ylva Molin, Kaija T. Salmela, Torbjörn Lundgren, Åsa Melhus, Olle Korsgren · 2012 · American Journal Of Pathology
T cells in type 1 diabetes: Instructors, regulators and effectors: A comprehensive review
Iria Maria Gomez-Touriño, Sefina Arif, Martin Eichmann, Mark Peakman · 2015 · Journal of Autoimmunity
B cell depletion therapy exacerbates murine primary biliary cirrhosis
Amy Dhirapong, Ana Lleò, Guo–Xiang Yang, Koichi Tsuneyama, Robert Dunn, Marilyn R. Kehry, Thomas Alexander Packard, John C. Cambier, Fu‐Tong Liu, Keith D. Lindor et al. · 2010 · Hepatology
Revisiting the notion of type 1 diabetes being a T-cell-mediated autoimmune disease
Oskar Skog, Stella Korsgren, Åsa Melhus, Olle Korsgren · 2013 · Current Opinion in Endocrinology Diabetes and Obesity
Therapeutic Targeting of Syk in Autoimmune Diabetes
Lucrezia Colonna, Geoffrey Catalano, Claude Chew, Vivette Denise D’Agati, James W. Thomas, Florence Susan Wong, Jochen Schmitz, Esteban S. Masuda, Boris Reizis, Alexander Tarakhovsky et al. · 2010 · The Journal of Immunology
T lymphocyte proliferation is suppressed by the opioid growth factor ([Met5]-enkephalin)–opioid growth factor receptor axis: Implication for the treatment of autoimmune diseases
Ian Stuart Zagon, Renee Nicole Donahue, Robert H. Bonneau, Patricia Jean McLaughlin · 2010 · Immunobiology
The rise, fall, and resurgence of immunotherapy in type 1 diabetes
Moufida Ben Nasr, Francesca D’Addio, Vera Usuelli, Sara Tezza, Reza Abdi, Paolo Fiorina · 2014 · Pharmacological Research
Endoplasmic reticulum stress in beta cells and autoimmune diabetes
Amy L. Clark, Fumihiko Urano · 2016 · Current Opinion in Immunology
The multiple origins of Type 1 diabetes
Alberto Pugliese · 2012 · Diabetic Medicine
Current and Future Immunomodulation Strategies to Restore Tolerance in Autoimmune Diseases
J. A. Bluestone, H. Bour-Jordan · 2012 · Cold Spring Harbor Perspectives in Biology
Beyond the Hormone: Insulin as an Autoimmune Target in Type 1 Diabetes
Vedran Brezar, Jean‐Claude Carel, Christian Boîtard, Roberto Mallone · 2011 · Endocrine Reviews
PTPN22 inhibition resets defective human central B cell tolerance
Jean‐Nicolas Schickel, Marcel Kuhny, Alessia Baldo, Jason M. Bannock, Christopher Massad, Haowei Wang, Nathan Katz, Tyler Oe, Laurence C. Menard, Pauline Soulas-Sprauel et al. · 2016 · Science Immunology
Dynamics of Islet Autoantibodies During Prospective Follow-Up From Birth to Age 15 Years
Petra M Pöllänen, Samppa J. Ryhänen, Jorma Toppari, Jorma Ilonen, Paula Vähäsalo, Riitta Veijola, Heli Siljander, Mikael Knip · 2020 · The Journal of Clinical Endocrinology & Metabolism
The New insights from DPP‐4 inhibitors: their potential immune modulatory function in autoimmune diabetes
Yunjuan Zhao, Lin Yang, Xiangbing Wang, Zhiguang Zhou · 2014 · Diabetes/Metabolism Research and Reviews
B Cell-Targeted Therapies for Systemic Lupus Erythematosus
R. John Looney · 2010 · Drugs
Promoting Immune Regulation in Type 1 Diabetes Using Low-Dose Interleukin-2
Connor J. Dwyer, Natasha C. Ward, Alberto Pugliese, Thomas R. Malek · 2016 · Current Diabetes Reports
Developing a vaccine for type 1 diabetes by targeting coxsackievirus B
Heikki Hyöty, Francisco Leon, Mikael Knip · 2018 · Expert Review of Vaccines
Combined therapy with CD4 + CD25highCD127 − T regulatory cells and anti‐CD20 antibody in recent‐onset type 1 diabetes is superior to monotherapy: Randomized phase I/ II trial
Maciej Zieliński, Magdalena Żalińska, Dorota Iwaszkiewicz‐Grześ, Mateusz Gliwiński, Matylda Hennig, Anna Jaźwińska-Curyłło, Halla Kamińska, Justyna Sakowska, Anna Wołoszyn‐Durkiewicz, Radosław Owczuk et al. · 2022 · Diabetes Obesity and Metabolism
Surrogate end points in the design of immunotherapy trials: emerging lessons from type 1 diabetes
Bart O. Roep, Mark Peakman · 2010 · Nature reviews. Immunology
C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: an individual participant meta-analysis
Peter Nicholas Taylor, Kimberly S. Collins, Anna P. Lam, Stephen R. Karpen, Brianna Greeno, Frank Walker, Alejandro Lozano, Elnaz Atabakhsh, Simi T. Ahmed, Marjana Marinac et al. · 2023 · The Lancet Diabetes & Endocrinology
IL-2 therapy in type 1 diabetes: “Trials” and tribulations
Sarah Alice Long, Jane Hoyt Buckner, Carla J. Greenbaum · 2013 · Clinical Immunology
Reduced antibody formation after influenza vaccination in patients with neuromyelitis optica spectrum disorder treated with rituximab
W. Kim, Seung Hyun Kim, So‐Young Huh, Sun‐Young Kong, Young Ju Choi, Hee Jin Cheong, Ho Jin Kim · 2013 · European Journal of Neurology
Elevated T cell levels in peripheral blood predict poor clinical response following rituximab treatment in new-onset type 1 diabetes
Peter S. Linsley, Carla J. Greenbaum, Mario G. Rosasco, Scott Presnell, Kevan C. Herold, Matthew J. Dufort · 2018 · Genes and Immunity
European dermatology forum: Updated guidelines on the use of extracorporeal photopheresis 2020 – Part 2
Robert Knobler, Petr Arenberger, A. Arun, Chalid Assaf, Martine Bagot, Gösta Berlin, Alain Bohbot, Piergiacomo Calzavara‐Pinton, Fiona J. Child, Ara Cho et al. · 2020 · Journal of the European Academy of Dermatology and Venereology
Molecular Targeting of Islet Autoantigens
Brian D. Stadinski, John W. Kappler, George S. Eisenbarth · 2010 · Immunity
Advances in our understanding of the pathophysiology of Type 1 diabetes: lessons from the NOD mouse
Abhirup Jayasimhan, Kristy P. Mansour, Robyn Maree Slattery · 2013 · Clinical Science
IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes
Carla J. Greenbaum, Elisavet Serti, Katharina Lambert, Lia J. Weiner, Sai Kanaparthi, Sandra M. Lord, Stephen Eric Gitelman, Darrell M. Wilson, Jason L. Gaglia, Kurt Griffin et al. · 2021 · JCI Insight